Innovent Biologics
$11.22
5
-$0.03-0.27% Tuesday 13:30
Statistics
Day High
11.22
Day Low
11.22
52W High
13.76
52W Low
5.49
Volume
2,000
Avg. Volume
-
Mkt Cap
0
P/E Ratio
160.29
Dividend Yield
-
Dividend
-
Upcoming
Earnings
26MarExpected
Expected EPS
0.0171552
Actual EPS
-0.0014296
Financials
-1.01%Profit Margin
Unprofitable2.58BRevenue
-26.16MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IVBXF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.42B
HUTCHMED (China) Limited
HCM
Mkt Cap2.29B
Sinovac Biotech
SVA
Mkt Cap642.44M
Can-Fite Biopharma
CANF
Mkt Cap7.11M
About
Innovent Biologics, Inc., a biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People's Republic of China, the United States, Europe, and internationally. The company discovers, develops, manufactures, and commercializes monoclonal antibodies and other drugs for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and metabolic diseases. Its commercial stage product portfolio includes TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), PEMAZYRE (pemigatinib), olverembatinib, Cyramza (ramucirumab), Retsevmo (selpercatinib), FUCASO (Equecabtagene Autoleucel), SINTBILO (tafolecimab injection), DUPERT (fulzerasib), DOVBLERON (taletrectinib adipate), Jaypirca (pirtobrutinib), limertinib, SYCUME (teprotumumab N01 injection), mazdutide, PECONDLE (picankibart injection), and TABOSUN(Ipilimumab N01 injection). In addition, it sells and distributes pharmaceutical products; and offers consultation and research and development services. The company was incorporated in 2011 and is headquartered in Suzhou, the People's Republic of China.
Show more...
CEO
Dr. De-Chao Yu Ph.D.
Employees
5659
Country
Cayman Islands
ISIN
KYG4818G1010
Listings
0 Comments
Share your thoughts
FAQ
What is Innovent Biologics stock price today?▼
The current price of IVBXF is $11.22 USD — it has decreased by -0.27% in the past 24 hours. Watch Innovent Biologics stock price performance more closely on the chart.
What is Innovent Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Innovent Biologics stocks are traded under the ticker IVBXF.
Is Innovent Biologics stock price growing?▼
IVBXF stock has risen by +1.29% compared to the previous week, the month change is a -5.63% fall, over the last year Innovent Biologics has showed a +63.2% increase.
When is the next Innovent Biologics earnings date?▼
Innovent Biologics is going to release the next earnings report on August 26, 2026.
What were Innovent Biologics earnings last quarter?▼
IVBXF earnings for the last quarter are -0 USD per share, whereas the estimation was 0.02 USD resulting in a -108.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innovent Biologics revenue for the last year?▼
Innovent Biologics revenue for the last year amounts to 2.58B USD.
What is Innovent Biologics net income for the last year?▼
IVBXF net income for the last year is -26.16M USD.
How many employees does Innovent Biologics have?▼
As of May 06, 2026, the company has 5,659 employees.
In which sector is Innovent Biologics located?▼
Innovent Biologics operates in the Health & Wellness sector.
When did Innovent Biologics complete a stock split?▼
Innovent Biologics has not had any recent stock splits.
Where is Innovent Biologics headquartered?▼
Innovent Biologics is headquartered in Suzhou, Cayman Islands.